- Current report filing (8-K)
October 25 2011 - 6:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of
1934
Date of Report (date of earliest event reported): October 21, 2011
DAVITA INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
1-14106
|
|
No. 51-0354549
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
1551 Wewatta Street
Denver, CO 80202
(Address of principal executive offices including Zip
Code)
(303) 405-2100
(Registrants telephone number, including area code)
Not
applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01.
|
Regulation FD Disclosure.
|
DaVita Inc.
(the Company) has been advised that it will be receiving a request for documents, which could include an administrative subpoena from the Office of Inspector General for the U.S. Department of Health and Human Services. The request is in
connection with an inquiry by the United States Attorneys office for the Eastern District of New York regarding payment for infusion drugs covered by the New York Medicaid composite payment system for dialysis. We believe this inquiry is civil
in nature. We do not know the time period covered by the inquiry.
We understand that certain other providers that operate dialysis clinics in
New York and provide services to New York Medicaid patients also may be receiving or have received a similar request for documents. We intend to cooperate with the government to provide responsive documents. To the Companys knowledge, no
proceedings have been initiated against it at this time, although the Company cannot predict whether proceedings might be initiated. Any negative findings could result in substantial financial penalties against the Company, exclusion from future
participation in the Medicare and Medicaid programs, and criminal penalties.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits.
|
|
|
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Press Release dated October 25, 2011
|
This Form 8-K and the attached Exhibit are furnished to comply with Item 7.01 of Form 8-K. Neither this Form 8-K nor
the attached Exhibit are to be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall this Form 8-K nor the attached Exhibit be deemed incorporated by reference in any filing under the Securities
Act of 1933 (except as shall be expressly set forth by specific reference in such filing).
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
DAVITA INC.
|
|
|
|
|
Date: October 25, 2011
|
|
|
|
By:
|
|
/
S
/ K
IM
M.
R
IVERA
|
|
|
|
|
|
|
Kim M. Rivera
|
|
|
|
|
|
|
Chief Legal Officer and Corporate Secretary
|
3
EXHIBIT INDEX
|
|
|
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Press Release dated October 25, 2011
|
4
DaVita (NYSE:DVA)
Historical Stock Chart
From Aug 2024 to Sep 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Sep 2023 to Sep 2024